Business and Finance Business and Finance
Wed, December 23, 2009
[ Wed, Dec 23rd 2009 ] - Market Wire
DEQ Issues Stock Options
[ Wed, Dec 23rd 2009 ] - Market Wire
Amelot Update Year End 2009

Re Juv by Caci Scores Big on Phase I Marketing Program


Published on 2009-12-23 05:05:22 - Market Wire
  Print publication without navigation


FORT LAUDERDALE, Fla.--([ BUSINESS WIRE ])--Cross Atlantic Commodities, Inc. (Pink Sheets:[ CXAC ]), a successful manufacturer of specialty health and beauty products, announced that it is entering Phase II, after a very successful marketing test program with its lead product Re Juv by Caci.

"While these numbers represent a formula based on the Phase I test results, I am bullish on their attainability"

"We are increasing the advertising on our Re Juv by Caci Marketing Programs. In 90 days, we have sold over 1500 packages [Our 3 Step Process.] and have achieved a better than 80% retention rate. Now that I know we have tremendous public acceptance to our beauty products, we can count on our financial backers and can rapidly move forward," said CEO Jorge Bravo.

The Company will start with a spend of $25,000 per week and increase to its Goal of $100,000 per week. As a result of this increase spend, sales are expected to increase in the 1st Quarter to $300,000, in the 2nd Quarter $600,000, 3rd Quarter $1.2M and 4th Quarter $1.5M. "While these numbers represent a formula based on the Phase I test results, I am bullish on their attainability," said Bravo.

The Company expects to add its newest product, Snorenz™ to the mix in the 2nd Quarter. The market for snoring products exceeds $2 billion. It will use the same marketing formula it has fine-tuned for its Re Juv by Caci™ product line.

About Cross Atlantic Commodities, Inc.

Cross Atlantic Commodities, Inc. develops, acquires, markets and distributes specialty "quality of life" enhancement products and general merchandise to the public via direct response marketing, direct marketing and eventually mass retail/wholesale distributors. Products the company is currently marketing can be viewed on its website.

This Press Release contains or incorporates by reference forward looking statements, including certain information with respect to plans and strategies of Cross Atlantic. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Cross Atlantic operations that could differ materially from those indicated by such forward looking statements.